Switching to CT-P13 Associated With Loss of Response in Patients With Behçet’s Disease – The Center for Biosimilars

Switching to CT-P13 Associated With Loss of Response in Patients With Behçet’s Disease – The Center for Biosimilars

Switching to CT-P13 Associated With Loss of Response in Patients With Behçet’s Disease – The Center for Biosimilars
Published on 2017-11-22